Log in to save to my catalogue

A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge

A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c9dbfd8736364f25b7884f0d5634e9e1

A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge

About this item

Full title

A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2020-12, Vol.11 (1), p.6402-6402, Article 6402

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The COVID-19 pandemic caused by SARS-CoV-2 imposes an urgent need for rapid development of an efficient and cost-effective vaccine, suitable for mass immunization. Here, we show the development of a replication competent recombinant VSV-∆G-spike vaccine, in which the glycoprotein of VSV is replaced by the spike protein of SARS-CoV-2. In-vitro chara...

Alternative Titles

Full title

A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c9dbfd8736364f25b7884f0d5634e9e1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c9dbfd8736364f25b7884f0d5634e9e1

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-020-20228-7

How to access this item